celecoxib has been researched along with Radiodermatitis in 2 studies
Radiodermatitis: A cutaneous inflammatory reaction occurring as a result of exposure to ionizing radiation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this randomized, placebo-controlled, double-blind study was to investigate the preventive effect of oral administration of celecoxib (CLX) on the acute radiation- induced skin toxicity in patients with breast cancer." | 9.27 | Randomized Double-blind Placebo-controlled Trial of Celecoxib for the Prevention of Skin Toxicity in Patients Receiving Radiation Therapy for Breast Cancer. ( Danesh, B; Ghasemi, A; Hosseinimehr, SJ; Yazdani-Charati, J, 2018) |
| "The purpose of this randomized, placebo-controlled, double-blind study was to investigate the preventive effect of oral administration of celecoxib (CLX) on the acute radiation- induced skin toxicity in patients with breast cancer." | 5.27 | Randomized Double-blind Placebo-controlled Trial of Celecoxib for the Prevention of Skin Toxicity in Patients Receiving Radiation Therapy for Breast Cancer. ( Danesh, B; Ghasemi, A; Hosseinimehr, SJ; Yazdani-Charati, J, 2018) |
| "Celecoxib-treated animals had less inflammation of the dermis compared with saline-treated controls." | 1.32 | Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor. ( Ding, I; Hu, D; Liang, L; Liu, W; Okunieff, P; Williams, JP, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghasemi, A | 1 |
| Danesh, B | 1 |
| Yazdani-Charati, J | 1 |
| Hosseinimehr, SJ | 1 |
| Liang, L | 1 |
| Hu, D | 1 |
| Liu, W | 1 |
| Williams, JP | 1 |
| Okunieff, P | 1 |
| Ding, I | 1 |
1 trial available for celecoxib and Radiodermatitis
| Article | Year |
|---|---|
Randomized Double-blind Placebo-controlled Trial of Celecoxib for the Prevention of Skin Toxicity in Patients Receiving Radiation Therapy for Breast Cancer.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Carcinoma, Ductal, Breast; Celecox | 2018 |
1 other study available for celecoxib and Radiodermatitis
| Article | Year |
|---|---|
Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor.
Topics: Animals; Breast Neoplasms; Celecoxib; Cell Line, Tumor; Chemokines; Cyclooxygenase 2; Cyclooxygenase | 2003 |